CERo Therapeutics 获得高达 $8M 的资金，以推进 MD Anderson 的癌症 T 细胞治疗试验。 CERo Therapeutics secures up to $8M to advance cancer T cell therapy trials at MD Anderson.

CERo 治疗技术公司是一家研制癌症高级细胞疗法的公司,已争取到800万美元的额外资金。 CERo Therapeutics, a company developing advanced T cell therapies for cancer, has secured up to $8 million in additional financing. 这笔钱将有助于推动MD Anderson癌症中心的临床试验和启动站点。 This money will help advance clinical trials and activate sites at MD Anderson Cancer Center. 该公司的主导产品旨在强化T细胞,以更有效地防治肿瘤,目前正在进行血癌试验。 The company's lead product, designed to enhance T cells to fight tumors more effectively, is currently in trials for blood cancers.